All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Prolonged response to pemetrexed-based chemotherapy in a patient with peritoneal mesothelioma: a case report and review of the literature

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15110%2F16%3A33160404" target="_blank" >RIV/61989592:15110/16:33160404 - isvavai.cz</a>

  • Result on the web

    <a href="https://www.degruyter.com/downloadpdf/j/pteridines.2016.27.issue-1-2/pterid-2015-0015/pterid-2015-0015.pdf" target="_blank" >https://www.degruyter.com/downloadpdf/j/pteridines.2016.27.issue-1-2/pterid-2015-0015/pterid-2015-0015.pdf</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1515/pterid-2015-0015" target="_blank" >10.1515/pterid-2015-0015</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Prolonged response to pemetrexed-based chemotherapy in a patient with peritoneal mesothelioma: a case report and review of the literature

  • Original language description

    Peritoneal mesothelioma is a rare tumor typically presenting with ascites and associated with occupational asbestos exposure with a latency period of 20-40 years. Intensive multi-modality approach combining cytoreductive surgery, intraperitoneal chemotherapy and possibly radiotherapy can be considered, but otherwise the prognosis is rather poor. Palliative chemotherapy may be an option in these rare cases. However, no approved systemic treatment exists for peritoneal mesothelioma. We present here a patient with peritoneal mesothelioma who was treated with the combination of pemetrexed with cisplatin shortly after the failure of hyperthermic intraperitoneal chemotherapy. The patient experienced durable partial response to the treatment, resolution of ascites, and returned to his normal daily life activities. With the exception of palliative chemotherapy in case of patients in good condition, therapeutic options in patients with peritoneal mesothelioma are currently very limited. The combination of pemetrexed and cisplatin can lead to long-term control in selected patients.

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

  • CEP classification

    FD - Oncology and haematology

  • OECD FORD branch

Result continuities

  • Project

    <a href="/en/project/LO1304" target="_blank" >LO1304: Support of suistainability of the Institute of Molecular and Translational Medicine</a><br>

  • Continuities

    P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Others

  • Publication year

    2016

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Pteridines

  • ISSN

    0933-4807

  • e-ISSN

  • Volume of the periodical

    27

  • Issue of the periodical within the volume

    1-2

  • Country of publishing house

    DE - GERMANY

  • Number of pages

    5

  • Pages from-to

    1-5

  • UT code for WoS article

    000377578800001

  • EID of the result in the Scopus database